Episode 34: A distinctly different treatment - Mark Lacey's approach to stage 4 prostate cancer

When Mark Lacey was diagnosed with metastatic prostate cancer, his PSA was 3,500 and his scan was lit up from head to toe. Less than a year later, most of the bone mets are gone. In this honest, hard-hitting conversation, Mark shares what worked and why he’s still here — still farming, still thinking, still fighting.Orchiectomy causes a flatline in testosterone, but doesn’t interfere with the brain’s signaling loop.This stabilizes hormonal levels — no peaks, valleys, or drug half-lives to manage.In some men, this steady state reduces cognitive side effects that were present on drug-based ADT.Orchiectomy eliminates fluctuations